Gene · 4627
Papers4,242
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 4,242
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ETS1-Driven Transcriptional Activation of USP43 Promotes Lenvatinib Resistance in Hepatocellular Carcinoma through MYH9 Stabilization and AKT/BAD Signaling. | Mol Cancer Res | 2026 | 41837877 | PubTator, text mining | PubMed |
| Synthetic aptamer mechanoreceptors enable cell-specific force sensing and temporal control via DNA circuits. | Nat Commun | 2026 | 41833970 | PubTator, text mining | PubMed |
| Identification of the MRTFA/SRF pathway as a critical regulator of quiescence and chemotherapy resistance in cancer. | Cancer Lett | 2026 | 41831517 | PubTator, text mining | PubMed |
| Exploring genetic drivers of unexplained venous thromboembolism through whole-exome sequencing. | Thromb Res | 2026 | 41831330 | PubTator, text mining | PubMed |
| MYH9 Variant p.(Arg424Gly) Alters Nonmuscle Myosin IIA Contraction, Causing Atypical MYH9-related Disease. | Kidney Int Rep | 2026 | 41799362 | PubTator, text mining | PubMed |
| Apolipoprotein L1 High-Risk Genotypes are Associated With Lupus Nephritis Incidence. | Kidney Int Rep | 2026 | 41799359 | PubTator, text mining | PubMed |
| A multi-glycoprotein synergized recombinant virus system resolved the research dilemma of Epstein-Barr virus entry and facilitated the development of entry-specific drugs or vaccines. | Curr Res Microb Sci | 2026 | 41798061 | PubTator, text mining | PubMed |
| O-GlcNAcylation Mediates BMP2-Induced Osteogenesis/Cementogenesis via NMIIA. | J Dent Res | 2026 | 41797004 | PubTator, text mining | PubMed |
| Clinical utility and genomic insights from whole exome and clinical exome sequencing in idiopathic liver disease. | Hum Mol Genet | 2026 | 41790749 | PubTator, text mining | PubMed |
| Differentially expressed proteins in plasma-derived extracellular vesicles from chronic myeloid leukemia patients. | Front Genet | 2026 | 41773228 | PubTator, text mining | PubMed |
| GFI1B mutations define an emerging form of inherited thrombocytopenia: insights from a case report and literature review. | Ann Hematol | 2026 | 41766040 | PubTator, text mining | PubMed |
| MYH9 mutations differentially stabilize non-muscle myosin II filaments and induce distinct cellular aggregation phenotypes. | Cell Mol Life Sci | 2026 | 41760963 | PubTator, text mining | PubMed |
| Blood Mechanical Intelligence: From Force Sensing to Precision Mechanomedicine. | Research (Wash D C) | 2026 | 41756726 | PubTator, text mining | PubMed |
| The dual roles of exosomes in prostate cancer: mechanisms in tumorigenesis and avenues for clinical translation. | Front Immunol | 2026 | 41756279 | PubTator, text mining | PubMed |
| Extracellular Vesicle-Based Biomarkers in Spinal Cord Injury: A State-of-the-Art Review on Diagnostic and Prognostic Advances. | Int J Mol Sci | 2026 | 41752215 | PubTator, text mining | PubMed |
| The Clinical Details of MYH9-Related Disease and DFNA17 in a Large Japanese Hearing Loss Cohort. | Genes (Basel) | 2026 | 41751538 | PubTator, text mining | PubMed |
| KIFC1 is Associated With Sarcomatoid Differentiation, Immune Response, and a Poor Prognosis in Clear Cell Renal Cell Carcinoma. | Cancer Med | 2026 | 41748316 | PubTator, text mining | PubMed |
| SMARCA4-Deficient Carcinomas of the Small Intestine: A Systematic Review. | Curr Oncol | 2026 | 41744871 | PubTator, text mining | PubMed |
| Clinical and Genetic Characterization of 269 Patients With Suspected Inherited Platelet Disorders: The Padua Monocentric Experience. | Int J Lab Hematol | 2026 | 41731342 | PubTator, text mining | PubMed |
| Src-dependent tyrosine-phosphorylation of NM2A has a protective role against bacterial pore-forming toxins. | PLoS Pathog | 2026 | 41729996 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4627/papers?page=4